FDA Inspection 1220575 — Glenmark Pharmaceuticals Ltd.
The FDA completed an inspection of Glenmark Pharmaceuticals Ltd. on September 29, 2023 in Navi Mumbai. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 29, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Navi Mumbai (India)
Additional Details
Bioanalytical BA/BE